Dentsply Sirona [XRAY] - Last Close: $29.55
News of a personnel change is lifting Densply Sirona this morning.
The dental equipment manufacturer announced after yesterday's closing bell that it had appointed a new Chief Financial Officer.
The company recruited Integra Lifesciences COO Glenn Coleman to take the helm as CFO, and he'll start his new position on Sept. 26th.
Coleman will replace interim CFO Barbara Bodem.
XRAY is leading the S&P 500 with a 3.0% premarket gain.
My Take: CFO is an important position, so investors were pleased to see the firm find someone to take the role on a permanent basis. However, I don't think it really changes the stock's long-term outlook.
Sellas Life Sciences Group [SLS] - Last Close: $2.31
Sellas Life Sciences says it will provide a key drug update at an upcoming conference.
The late-stage clinical biotech firm said this morning that it will host a poster presentation related to its CDK9 inhibitor, GFH009, at the upcoming Tenth Annual Meeting of the Society of Hematologic Oncology (SOHO).
Sellas will make its presentation on Wednesday, Sept. 28th, at 6:05 p.m., with Senior VP of Clinical Development Dragan Cicic serving as host.
According to a company press release, the poster presentation characterizes the preclinical pharmacokinetic (PK) profiles of two different formulations of GFH009 maleate, pH 4.5 and pH 6.0.
Shares of SLS are up 24.2% in today's premarket.
My Take: It sounds like SLS is getting ready to unveil some positive data at this conference next week, and investors are positioning themselves in anticipation of the potential rally catalyst.
However, it's anyone's guess whether the presentation will live up to this early hype, so don't get tricked into over-paying if you decide to get in this one.
